Blockchain Registration Transaction Record

Oncotelic & TechForce Robotics Partner on AI-Powered Pharma Automation Platform

Oncotelic Therapeutics partners with TechForce Robotics to commercialize AI-enabled robotics platform for pharmaceutical manufacturing, combining AI capabilities with robotics expertise for automated compliance solutions.

This partnership represents a significant advancement in pharmaceutical manufacturing technology that could accelerate drug development and improve patient access to treatments. By combining artificial intelligence with robotics in a GMP-compliant system, the collaboration addresses critical industry challenges including manufacturing consistency, regulatory compliance, and production scalability. For patients, this could translate to faster development of oncology and immunotherapy treatments, particularly for rare diseases and pediatric indications where Oncotelic specializes. For the pharmaceutical industry, the technology promises to reduce production costs, minimize human error, and streamline compliance processes in highly regulated environments. As drug manufacturing becomes increasingly complex with biologics and personalized medicines, such intelligent automation solutions could become essential infrastructure for the next generation of pharmaceutical production.